01 9Zoloft
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 294
2018 Revenue in Millions : 298
Growth (%) : -1
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 246
2021 Revenue in Millions : 284
Growth (%) : -13
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 236
2022 Revenue in Millions : 246
Growth (%) : -4
Main Therapeutic Indication : Neuroscience/Mental Health
Currency : USD
2014 Revenue in Millions : -9.60%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Neuroscience and Mental Health
Currency : USD
2015 Revenue in Millions : 423
2014 Revenue in Millions : 374
Growth (%) : -12%
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2016 Revenue in Millions : 304
2015 Revenue in Millions : 374
Growth (%) : -19
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 291
2016 Revenue in Millions : 304
Growth (%) : -4
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2018 Revenue in Millions : 299
2017 Revenue in Millions : 291
Growth (%) : 3%
Upjohn (9 months)
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 233
2019 Revenue in Millions : 217
Growth (%) : 7
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?